ImpediMed Ltd - Company Profile
Powered by 
All the sales intelligence you need on ImpediMed Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ImpediMed Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ImpediMed Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ImpediMed Ltd (ImpediMed) develops innovative medical devices using bioimpedance spectroscopy (BIS) to assess and monitor fluid status and tissue composition. Its lead product, the SOZO Digital Health Platform, is designed for the early detection and management of lymphedema, including breast cancer-related lymphedema (BCRL). SOZO offers accurate, non-invasive measurements, including the L-Dex score for fluid changes, and integrates with electronic health records for efficient care coordination. The company has introduced SOZO Pro, a next-generation platform which is designed to support advanced fluid and body composition monitoring across broader clinical settings, including heart failure and weight management. ImpediMed is headquartered in Carlsbad, the US.
Headquarters
Australia
Address
Unit 1 50 Parker Court, Brisbane, Queensland, 4008
Website
www.impedimed.com
Telephone
1 760 5852100
No of Employees
77
Industry
Medical Equipment
Ticker Symbol & Exchange
IPD (ASX)
Revenue (2024)
$8.4M
23.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-17.4%
(2024 vs 2023)
Market Cap*
$15.3M
Net Profit Margin (2024)
XYZ
4.8%
(2024 vs 2023)
* As of and is in US$
ImpediMed Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| SOZO Digital Health Platform |
| SOZO Pro |
Competitor Comparison
| Key Parameters | ImpediMed Ltd | Apyx Medical Corp | SELVAS Healthcare Inc | Hyperfine Inc | Milestone Scientific Inc |
|---|---|---|---|---|---|
| Headquarters | Australia | United States of America | South Korea | United States of America | United States of America |
| City | Brisbane | Clearwater | Daejeon | Guilford | Roseland |
| State/Province | Queensland | Florida | - | Connecticut | New Jersey |
| No. of Employees | 77 | 205 | 1 | 102 | 15 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Erik Anderson | Managing Director; Director; Chief Executive Officer | Executive Board | 2026 | - |
| McGregor Grant | Director; Chief Financial Officer | Executive Board | 2023 | - |
| Steven Chen | Chief Medical Officer | Senior Management | 2023 | - |
| Christine Emmanuel-Donnelly | Chairperson | Non Executive Board | 2023 | - |
| Dennis Schlaht | Senior Vice President - R&D and Technology | Senior Management | 2007 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer